FAKTOR-OPTIONSSCHEIN - AVID BIOSERVICES Share Price

Certificat

DE000ME0V2X4

Market Closed - Börse Stuttgart 20:17:19 31/05/2024 BST
0.204 EUR +4.08% Intraday chart for FAKTOR-OPTIONSSCHEIN - AVID BIOSERVICES
1 month+1.49%
3 months-87.33%
Date Price Change
31/05/24 0.204 +4.08%
30/05/24 0.196 -5.31%
29/05/24 0.207 -20.38%
28/05/24 0.26 -3.70%
27/05/24 0.27 -.--%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 08:17 pm

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying AVID BIOSERVICES, INC.
Issuer Morgan Stanley
WKN ME0V2X
ISINDE000ME0V2X4
Date issued 20/09/2023
Strike 5.301 $
Maturity Unlimited
Parity 12.06 : 1
Emission price 10
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 10.59
Lowest since issue 0.112

Company Profile

Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company provides a range of services from process development to Current Good Manufacturing Practices (CGMP) clinical and commercial manufacturing of biologics for the biotechnology and biopharmaceutical industries. It operates in a single segment, which is contract manufacturing and development services. The Company’s services include clinical and commercial product manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The Company also provides a variety of process development services, including upstream and downstream development and optimization, analytical methods development, testing and characterization. It provides fully integrated and customized biomanufacturing services that support its customers from the early preclinical stage to commercial launch and supply.
Sector
-
More about the company

Ratings for Avid Bioservices, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Consensus: Avid Bioservices, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
8.09 USD
Average target price
12.5 USD
Spread / Average Target
+54.51%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW